albendazole has been researched along with Cranial Nerve III Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ranjith, MP | 1 |
Divya, R | 1 |
Sahni, A | 1 |
Mesraoua, B | 1 |
Deleu, D | 1 |
D'souza, A | 1 |
Imam, YZ | 1 |
Melikyan, G | 1 |
Chotmongkol, V | 1 |
Sawanyawisuth, K | 1 |
Limpawattana, P | 1 |
Phuphatham, A | 1 |
Chotmongkol, R | 1 |
Intapan, PM | 1 |
3 other studies available for albendazole and Cranial Nerve III Diseases
Article | Year |
---|---|
Isolated third cranial nerve palsy: a rare presentation of neurocysticercosis.
Topics: Adolescent; Albendazole; Anti-Inflammatory Agents; Anticestodal Agents; Dexamethasone; Humans; Male; | 2011 |
Neurocysticercosis presenting as a vertical one-and-a-half syndrome with associated contralesional horizontal gaze paresis.
Topics: Abducens Nerve Diseases; Adult; Albendazole; Anthelmintics; Blepharoptosis; Dexamethasone; Diagnosis | 2012 |
Superior divisional oculomotor nerve palsy caused by midbrain neurocysticercosis.
Topics: Adult; Albendazole; Anticestodal Agents; Female; Humans; Magnetic Resonance Imaging; Mesencephalon; | 2006 |